Portolan Capital Management’s Tempest Therapeutics TPST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-227	Closed	-$1.02M	–	139
2016 Q4	$1.02M	Sell	227 -68	-23%	-$305K	0.14%	116
2016 Q3	$6.18M	Buy	295 +158	+115%	+$3.31M	0.85%	45
2016 Q2	$2.09M	Buy	137 +3	+2%	+$45.7K	0.3%	94
2016 Q1	$3.72M	Buy	+134	New	+$3.72M	0.5%	72